Minocycline Impact on Redox Homeostasis of Normal Human Melanocytes HEMn-LP Exposed to UVA Radiation and Hydrogen Peroxide
Minocycline is a semisynthetic tetracycline antibiotic. In addition to its antibacterial activity, minocycline shows many non-antibiotic, beneficial effects, including antioxidative action. The property is responsible, e.g., for anti-inflammatory, neuroprotective, and cardioprotective effects of the drug. However, long-term pharmacotherapy with minocycline may lead to hyperpigmentation of the skin. The reasons for the pigmentation disorders include the deposition of the drug and its metabolites in melanin-containing cells and the stimulation of melanogenesis. The adverse drug reaction raises a question about the influence of the drug on melanocyte homeostasis. The study aimed to assess the effect of minocycline on redox balance in human normal melanocytes HEMn-LP exposed to hydrogen peroxide and UVA radiation. The obtained results indicate that minocycline induced oxidative stress in epidermal human melanocytes. The drug inhibited cell proliferation, decreased the level of reduced thiols, and stimulated the activity of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx). The described changes were accompanied by an increase in the intracellular level of ROS. On the other hand, pretreatment with minocycline at the same concentrations increased cell viability and significantly attenuated the oxidative stress in melanocytes exposed to hydrogen peroxide and UVA radiation. Moreover, the molecular docking analysis revealed that the different influence of minocycline and other tetracyclines on CAT activity can be related to the location of the binding site.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
---|---|
Enthalten in: |
International journal of molecular sciences - 22(2021), 4 vom: 06. Feb. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Rok, Jakub [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 03.09.2021 Date Revised 03.09.2021 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.3390/ijms22041642 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM321222423 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM321222423 | ||
003 | DE-627 | ||
005 | 20231225175341.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/ijms22041642 |2 doi | |
028 | 5 | 2 | |a pubmed24n1070.xml |
035 | |a (DE-627)NLM321222423 | ||
035 | |a (NLM)33561995 | ||
035 | |a (PII)1642 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Rok, Jakub |e verfasserin |4 aut | |
245 | 1 | 0 | |a Minocycline Impact on Redox Homeostasis of Normal Human Melanocytes HEMn-LP Exposed to UVA Radiation and Hydrogen Peroxide |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.09.2021 | ||
500 | |a Date Revised 03.09.2021 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Minocycline is a semisynthetic tetracycline antibiotic. In addition to its antibacterial activity, minocycline shows many non-antibiotic, beneficial effects, including antioxidative action. The property is responsible, e.g., for anti-inflammatory, neuroprotective, and cardioprotective effects of the drug. However, long-term pharmacotherapy with minocycline may lead to hyperpigmentation of the skin. The reasons for the pigmentation disorders include the deposition of the drug and its metabolites in melanin-containing cells and the stimulation of melanogenesis. The adverse drug reaction raises a question about the influence of the drug on melanocyte homeostasis. The study aimed to assess the effect of minocycline on redox balance in human normal melanocytes HEMn-LP exposed to hydrogen peroxide and UVA radiation. The obtained results indicate that minocycline induced oxidative stress in epidermal human melanocytes. The drug inhibited cell proliferation, decreased the level of reduced thiols, and stimulated the activity of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx). The described changes were accompanied by an increase in the intracellular level of ROS. On the other hand, pretreatment with minocycline at the same concentrations increased cell viability and significantly attenuated the oxidative stress in melanocytes exposed to hydrogen peroxide and UVA radiation. Moreover, the molecular docking analysis revealed that the different influence of minocycline and other tetracyclines on CAT activity can be related to the location of the binding site | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a UVA radiation | |
650 | 4 | |a antioxidant | |
650 | 4 | |a antioxidant enzymes | |
650 | 4 | |a melanocytes | |
650 | 4 | |a minocycline | |
650 | 4 | |a oxidative stress | |
650 | 7 | |a Antioxidants |2 NLM | |
650 | 7 | |a Melanins |2 NLM | |
650 | 7 | |a Sulfhydryl Compounds |2 NLM | |
650 | 7 | |a Hydrogen Peroxide |2 NLM | |
650 | 7 | |a BBX060AN9V |2 NLM | |
650 | 7 | |a Catalase |2 NLM | |
650 | 7 | |a EC 1.11.1.6 |2 NLM | |
650 | 7 | |a Glutathione Peroxidase |2 NLM | |
650 | 7 | |a EC 1.11.1.9 |2 NLM | |
650 | 7 | |a Superoxide Dismutase |2 NLM | |
650 | 7 | |a EC 1.15.1.1 |2 NLM | |
650 | 7 | |a Minocycline |2 NLM | |
650 | 7 | |a FYY3R43WGO |2 NLM | |
700 | 1 | |a Rzepka, Zuzanna |e verfasserin |4 aut | |
700 | 1 | |a Maszczyk, Mateusz |e verfasserin |4 aut | |
700 | 1 | |a Beberok, Artur |e verfasserin |4 aut | |
700 | 1 | |a Wrześniok, Dorota |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of molecular sciences |d 2008 |g 22(2021), 4 vom: 06. Feb. |w (DE-627)NLM185552161 |x 1422-0067 |7 nnns |
773 | 1 | 8 | |g volume:22 |g year:2021 |g number:4 |g day:06 |g month:02 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/ijms22041642 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 22 |j 2021 |e 4 |b 06 |c 02 |